The standard dose versus double dose of N-acetylcysteine to prevent contrast-induced nephropathy; a randomized controlled clinical trial
Background: Contrast-induced acute kidney injury (CI-AKI) is one of the possible complications in angiography, which its prevention is important. N-acetylcysteine is one of the compounds that has recently been more investigated regarding its effect on CI-AKI. Objectives: The aim of this study was to...
Main Authors: | Rahimeh Eskandarian, Maliheh Yarmohamadi, Maryam Zaker-Tavalae, Majid Mirmohammadkhani, Marjan Biglari, Mohammad Reza Tamadon, Tahereh Jalali |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2018-07-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/jnp-7-145.pdf |
Similar Items
-
Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
by: Morteza Arabmomeni, et al.
Published: (2015-01-01) -
Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
by: Ji Hwan Lee, et al.
Published: (2017-04-01) -
Comparing the Effect of Vitamin E and N-Acetylcysteine on Prevention of Contrast-Induced Nephropathy in Diabetic Patients under Coronary Angiography
by: Mehdi Pishgahi, et al.
Published: (2021-01-01) -
Silymarin for the prevention of contrast-induced nephropathy: A placebo-controlled clinical trial
by: Zohreh Sedighifard, et al.
Published: (2016-01-01) -
Short‐Term High‐Dose Vitamin E to Prevent Contrast Medium–Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo‐Controlled Trial
by: Yousef Rezaei, et al.
Published: (2016-03-01)